Judit K.
- Country
- Hungary
- Department
- Pulmonology Department
Research Overview
Data & Insights
Has run more than one trial at 31 of 208 partner sites.
Specializations
Lung Cancer Expertise
This investigator specializes in advanced treatment approaches for non-small cell lung cancer (NSCLC), with particular focus on stage II through IIIB disease states.
- Advanced NSCLC Management
- Stage II-IIIB Treatment Protocols
- Adjuvant Therapy Applications
Their research encompasses novel therapeutic combinations for treating resectable lung cancer cases.
Immunotherapy Research
The investigator demonstrates expertise in immunotherapy approaches, particularly focusing on PD-L1 expression in lung cancer treatment strategies.
- PD-L1 High Expression Treatments
- Combination Immunotherapy Protocols
- First-line Treatment Strategies
Their work explores innovative immunotherapeutic combinations for previously untreated lung cancer patients.
Treatment Innovation
The investigator focuses on developing novel therapeutic combinations for lung cancer treatment, incorporating both established and experimental approaches.
- Combination Therapy Development
- Disease-Free Survival Assessment
- Treatment Response Evaluation
Their research aims to advance treatment options for various stages of non-small cell lung cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.